End-of-year victory for lawmakers as health care policies pass in the House; insurance limitations prompt concerns over access to semaglutide (Ozempic) for diabetes; a legal battle ensues over the fate of abortion laws in Arizona.
The House passed a significant health care package in a bipartisan 320-71 vote, marking an end-of-year accomplishment after previous setbacks, according to Stat. While the bill is unlikely to pass the Senate in its current form, the policies, including equalizing drug administration payments in Medicare across hospital outpatient departments and physician offices, addressing pharmacy benefit manager practices, and implementing health care price transparency rules, gain visibility for potential inclusion in a government funding deal. The most debated aspect, the Lower Costs, More Transparency Act, featuring site-neutral payments for drug administration, faces opposition from hospitals concerned about potential financial consequences and broader Medicare implications.
Some patients with type 2 diabetes are experiencing challenges in getting reimbursed for drugs like semaglutide (Ozempic) due to US insurers implementing restrictions to discourage prescribing the medication for weight loss, according to Reuters. Novo Nordisk acknowledged tighter health plan management of glucagon-like peptide-1 drugs, contributing to a recent decline in US prescriptions. Patients report delays and obstacles, including prior authorization requirements and the need to try alternative medications, raising concerns about potential impacts on diabetes management and overall health outcomes.
The Arizona State Supreme Court is set to hear oral arguments regarding the potential reinstatement of a centuries-old near-total abortion ban, with conflicting laws causing uncertainty after the US Supreme Court overturned Roe v Wade, according to ABC News. The current 15-week abortion ban in Arizona faces challenges, and the court will decide whether the 1864 law, which bans abortion with criminal penalties, will be enforced. Planned Parenthood Arizona aims to affirm the Court of Appeals' decision to preserve abortion access, while abortion advocates simultaneously seek a ballot measure to secure abortion rights in the state's constitution.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
April 2nd 2025A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear communication regarding their potential impact on American health.
Read More